Timing matters: Unveiling the distinct effects of early- versus late-onset pre-eclampsia on mothers and newborns in a tertiary hospital in Bangladesh
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Pre-eclampsia (PE) is a significant cause of maternal and perinatal morbidity and mortality worldwide. The clinical course and severity of PE can vary depending on the gestational age at onset. However, limited data from developing countries including Bangladesh stratify outcomes by onset timing, hindering context-specific management. This study aimed to differentiate maternal and perinatal outcomes associated with early-onset PE (EO-PE, <34 weeks) versus late-onset PE (LO-PE, ≥34 weeks) in a tertiary care setting in Bangladesh.
Methods
A cross-sectional study was conducted at Faridpur Medical College Hospital, Faridpur, Bangladesh, from March to August 2023. Data were collected from hospital records and through pre-structured telephone questionnaires for 255 mothers diagnosed with PE (EO-PE: n=121; LO-PE: n=134). Maternal, fetal and neonatal outcomes were compared between the EO-PE and LO-PE groups.
Results
The prevalence of PE was 11.28%. EO-PE was associated with more adverse perinatal outcomes compared to LO-PE, including higher rates of prematurity, low birth weight, and increased need for neonatal hospital admission. Maternal complications such as eclampsia (31% vs 19%) and placental abruption (20% vs 10%) were more frequent in the EO-PE group. In multivariable regression, EO-PE was not independently associated with maternal adverse outcomes but showed significantly higher odds of stillbirth (aOR: 17.7, 95% CI: 6.15-66.7, p<0.001) and neonatal adverse outcomes (aOR: 5.33, 95% CI: 2.96-9.83, p<0.001).
Conclusions
Early-onset PE is associated with more severe adverse perinatal outcomes compared to late-onset PE. Onset-based classification, early screening, and targeted management strategies are recommended to reduce the burden of pre-eclampsia.
